Nancy Simonian is the founder of Syros Pharmaceuticals. Syros Pharmaceuticals has raised $123M in total funding. Based in Cambridge, MA.
Nancy Simonian is the founding CEO of Syros Pharmaceuticals, a company focused on using small molecules to control gene expression for developing therapies for cancer and monogenic diseases. She joined Syros in 2012 and has led its transformation from a discovery-stage company to a publicly traded clinical-stage company with multiple product candidates. Under her leadership, Syros has raised capital both privately and in public markets.
Full founder directory · Investor directory · Company funding database · Fundraising library